Li Z - Search Results

1

CTR-FAPI PET enables precision management of medullary thyroid carcinoma.

Kong Z, Li Z, Cui XY, Wang J, Xu M, Liu Y, Chen J, Ni S, Zhang Z, Fan X, Huang J, Lin Y, Sun Y, He Y, Lin X, Meng T, Li H, Song Y, Peng B, An C, Gao C, Li N, Liu C, Zhu Y, Yang Z, Liu Z, Liu S. Kong Z, et al. Among authors: li z, li h, li n. Cancer Discov. 2024 Oct 29. doi: 10.1158/2159-8290.CD-24-0897. Online ahead of print. Cancer Discov. 2024. PMID: 39470165

2

¹⁸F-Boramino acid PET/CT in healthy volunteers and glioma patients.

Li Z, Kong Z, Chen J, Li J, Li N, Yang Z, Wang Y, Liu Z. Li Z, et al. Among authors: li j, li n. Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3113-3121. doi: 10.1007/s00259-021-05212-7. Epub 2021 Feb 15. Eur J Nucl Med Mol Imaging. 2021. PMID: 33590273

3

Metabolic characteristics of [¹⁸F]fluoroboronotyrosine (FBY) PET in malignant brain tumors.

Kong Z, Li Z, Chen J, Liu S, Liu D, Li J, Li N, Ma W, Feng F, Wang Y, Yang Z, Liu Z. Kong Z, et al. Among authors: li z, li j, li n. Nucl Med Biol. 2022 Mar-Apr;106-107:80-87. doi: 10.1016/j.nucmedbio.2022.01.002. Epub 2022 Jan 10. Nucl Med Biol. 2022. PMID: 35091195

4

Larger ¹⁸F-fluoroboronotyrosine (FBY) active volume beyond MRI contrast enhancement in diffuse gliomas than in circumscribed brain tumors.

Kong Z, Li Z, Chen J, Ma W, Wang Y, Yang Z, Liu Z. Kong Z, et al. Among authors: li z. EJNMMI Res. 2022 Apr 18;12(1):22. doi: 10.1186/s13550-022-00896-w. EJNMMI Res. 2022. PMID: 35435593 Free PMC article.

5

Organotrifluoroborate enhances tumor targeting of fibroblast activation protein inhibitors for targeted radionuclide therapy.

Liu Y, Tang H, Song T, Xu M, Chen J, Cui XY, Han Y, Li Z, Liu Z. Liu Y, et al. Among authors: li z. Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2636-2646. doi: 10.1007/s00259-023-06230-3. Epub 2023 Apr 27. Eur J Nucl Med Mol Imaging. 2023. PMID: 37103565

6

An antibody-radionuclide conjugate targets fibroblast activation protein for cancer therapy.

Xu M, Chen J, Zhang P, Cai J, Song H, Li Z, Liu Z. Xu M, et al. Among authors: li z. Eur J Nucl Med Mol Imaging. 2023 Sep;50(11):3214-3224. doi: 10.1007/s00259-023-06300-6. Epub 2023 Jun 15. Eur J Nucl Med Mol Imaging. 2023. PMID: 37318538

7

A bis-boron boramino acid PET tracer for brain tumor diagnosis.

Li Z, Chen J, Kong Z, Shi Y, Xu M, Mu BS, Li N, Ma W, Yang Z, Wang Y, Liu Z. Li Z, et al. Among authors: li n. Eur J Nucl Med Mol Imaging. 2024 May;51(6):1703-1712. doi: 10.1007/s00259-024-06600-5. Epub 2024 Jan 9. Eur J Nucl Med Mol Imaging. 2024. PMID: 38191817

8

A histogram of [¹⁸F]BBPA PET imaging differentiates non-neoplastic lesions from malignant brain tumors.

Kong Z, Li Z, Chen J, Shi Y, Li N, Ma W, Wang Y, Yang Z, Liu Z. Kong Z, et al. Among authors: li z, li n. EJNMMI Res. 2024 Feb 2;14(1):12. doi: 10.1186/s13550-024-01069-7. EJNMMI Res. 2024. PMID: 38305994 Free PMC article. No abstract available.

9

Correction to: A bis-boron boramino acid PET tracer for brain tumor diagnosis.

Li Z, Chen J, Kong Z, Shi Y, Xu M, Mu BS, Li N, Ma W, Yang Z, Wang Y, Liu Z. Li Z, et al. Among authors: li n. Eur J Nucl Med Mol Imaging. 2024 May;51(6):1796-1797. doi: 10.1007/s00259-024-06678-x. Eur J Nucl Med Mol Imaging. 2024. PMID: 38517519 No abstract available.

10

Covalent targeted radioligands potentiate radionuclide therapy.

Cui XY, Li Z, Kong Z, Liu Y, Meng H, Wen Z, Wang C, Chen J, Xu M, Li Y, Gao J, Zhu W, Hao Z, Huo L, Liu S, Yang Z, Liu Z. Cui XY, et al. Among authors: li y, li z. Nature. 2024 Jun;630(8015):206-213. doi: 10.1038/s41586-024-07461-6. Epub 2024 May 22. Nature. 2024. PMID: 38778111

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113,180 results

Search Page

Filters